Lv11
20 积分 2025-01-25 加入
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
2小时前
待确认
Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II study
18天前
已完结
Emerging HER2-directed therapeutic agents for gastric cancer in early phase clinical trials
18天前
已完结
Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapy
18天前
已完结
皖公网安备34019202002308
